Abstract

The cost of genome sequencing and wearable sensors have dropped dramatically over the past decade. These trends, in combination with easier data-collection and data sharing over the internet, are providing fuel for exciting discoveries in precision medicine. At the same time, concern about data privacy and fairness in the way data is used and monetised continues to rise.

This talk will cover some of the latest advances in precision medicine including: - diagnosis and treatment of rare disorders (more than 6,000 rare diseases affect nearly 5% of the population) - pharmacogenomics (how drug safety/efficacy is affected by our individual genetics) - polygenic risk scores (using large amounts of genomic and other health data to predict common diseases including breast cancer, cardiovascular disease, and diabetes)

I will discuss some of the approaches we are taking at Sano Genetics to progress research in each of these areas, while providing individuals with full control of their health data and transparency around how it is used.